Matterhorn Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-17,941
| Closed | -$3.11M | – | 59 |
|
|
2015
Q1 | $3.11M | Buy |
17,941
+262
| +1% | +$45.4K | 1.39% | 47 |
|
|
2014
Q4 | $3.27M | Buy |
17,679
+4,867
| +38% | +$901K | 1.53% | 41 |
|
|
2014
Q3 | $2.13M | Sell |
12,812
-1,653
| -11% | -$274K | 0.95% | 53 |
|
|
2014
Q2 | $2.26M | Sell |
14,465
-155
| -1% | -$24.2K | 1% | 54 |
|
|
2014
Q1 | $2.19M | Sell |
14,620
-504
| -3% | -$75.3K | 1.01% | 53 |
|
|
2013
Q4 | $2.01M | Buy |
15,124
+464
| +3% | +$61.7K | 0.93% | 54 |
|
|
2013
Q3 | $1.7M | Buy |
14,660
+75
| +0.5% | +$8.71K | 0.85% | 53 |
|
|
2013
Q2 | $1.35M | Buy |
+14,585
| New | +$1.35M | 0.74% | 52 |
|